What is the treatment for ascites, particularly in patients with cirrhosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ascites in Cirrhosis

The first-line treatment for patients with cirrhosis and ascites consists of sodium restriction (88 mmol/day [2000 mg/day]) and diuretics (oral spironolactone and furosemide). 1

Diagnostic Approach

Before initiating treatment, proper diagnosis is essential:

  1. Diagnostic paracentesis should be performed in all cirrhotic patients with ascites on hospital admission 1

    • Include ascitic fluid cell count and differential
    • Measure serum-ascites albumin gradient (SAAG)
    • Culture ascitic fluid at bedside in blood culture bottles if infection is suspected
  2. Laboratory evaluation

    • SAAG ≥1.1 g/dL indicates portal hypertension 1
    • Ascitic fluid should be examined for neutrophil count to rule out spontaneous bacterial peritonitis (SBP)

Treatment Algorithm

First-Line Treatment

  1. Dietary sodium restriction

    • Limit to 88-90 mmol/day (2000 mg/day) 1, 2
    • No added salt diet
  2. Diuretic therapy

    • Initial approach: Start with spironolactone alone 100 mg/day 1, 2, 3
    • Increase spironolactone gradually up to 400 mg/day if needed 1
    • If inadequate response, add furosemide 20-40 mg/day, which can be increased up to 160 mg/day 1, 4
    • Target weight loss: 300-500 g/day in patients without peripheral edema 5

Management of Tense Ascites

  1. Large volume paracentesis (LVP) for patients with tense ascites 1
    • Follow with sodium restriction and oral diuretics to prevent reaccumulation
    • Volume expansion is required:
      • For paracentesis <5 liters: synthetic plasma expander (150-200 ml of gelofusine or haemaccel) 1
      • For paracentesis >5 liters: albumin (8 g/L of ascites removed) 1, 6

Management of Refractory Ascites

Refractory ascites is defined as:

  • Unresponsive to sodium restriction and high-dose diuretics (400 mg/day spironolactone and 160 mg/day furosemide) 1
  • Or recurs rapidly after therapeutic paracentesis

Treatment options:

  1. Serial therapeutic paracentesis with albumin replacement 1
  2. Transjugular intrahepatic portosystemic shunt (TIPS) for patients requiring frequent paracentesis 1, 6
    • Best for patients with relatively preserved liver function
  3. Liver transplantation evaluation 1, 2

Special Considerations

Hyponatremia Management

  • Fluid restriction is not necessary unless serum sodium is less than 120-125 mmol/L 1
  • For serum sodium 121-125 mmol/L with normal creatinine: consider stopping diuretics 1
  • For serum sodium <120 mmol/L: stop diuretics and consider volume expansion 1

Spontaneous Bacterial Peritonitis (SBP)

  • Empiric antibiotic therapy should be started if ascitic fluid neutrophil count >250 cells/mm³ 1
  • Third-generation cephalosporins are recommended 1
  • All patients with SBP should be considered for liver transplantation 1

Monitoring and Follow-up

  • Monitor weight, urinary sodium excretion, serum electrolytes, and renal function 1
  • Frequency of follow-up depends on response to treatment and patient stability 1
  • Initial evaluation every 2-4 weeks until stable, then every few months 1

Important Cautions

  • Avoid NSAIDs and other prostaglandin inhibitors as they can reduce urinary sodium excretion and induce azotemia 1, 2
  • Avoid nephrotoxic drugs in patients with ascites 2
  • Bed rest is not recommended for treatment of ascites 1
  • For patients with alcoholic liver disease, abstinence from alcohol is crucial for improving outcomes 1, 5

Long-term Management

  • Liver transplantation should be considered in all patients with cirrhotic ascites, as it is the ultimate treatment for ascites and its complications 1, 2
  • Development of ascites is an important landmark in the natural history of cirrhosis and should be considered as an indication for transplantation evaluation 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Liver Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of cirrhotic ascites.

Acta gastro-enterologica Belgica, 2007

Research

Management of ascites in cirrhosis.

Journal of gastroenterology and hepatology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.